Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Propionate/Salmeterol in Patients with Asthma

- Persistent Asthma
- Completed

Study Title: Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Teva Identifier: FSS-AS-305

ClinicalTrials.gov Identifier: NCT02175771

Study Status: Completed

Trial Condition(s): Persistent Asthma

Interventions: Drug: Fp MDPI | Drug: FS MDPI | Drug: FLOVENT HFA | Drug: ADVAIR DISKUS | Drug: albuterol/salbutamol HFA

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: 07/01/2014 - 07/01/2015

Phase: Phase 3

Study Type

Interventional